跳至主要内容
临床试验/NCT03374735
NCT03374735已完成不适用

Prospective, Multicenter, Non-controlled Study, Evaluating Safety and Performance of SETALUM™ Sealant as an add-on to Suture in Vascular Reconstruction in Patients Undergoing Carotid Enlargement Procedure Using an ePTFE Patch.

Gecko Biomedical0 个研究点目标入组 22 人开始时间: 2016年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
主要终点
Elapsed time from clamp release to hemostasis at the suture line

研究概览

简要总结

This is a prospective, multicenter, single-arm trial to evaluate the safety and performance of SETALUM™ Sealant in sealing suture lines at the anastomosis between native vessels and synthetic ePTFE vascular patch used during open vascular surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •≥18 years old;
  • •Surgical placement of an ePTFE patch for large carotid repair;
  • •Written informed consent given by the patient.

排除标准

  • •Known or suspected allergy or sensitivity to any test materials or reagents;
  • •Concomitant intake of immunosuppressive medications;
  • •Prior radiation therapy to the operating field;
  • •Previous surgical procedure performed on the same operating field;
  • •Current or recent (<3months) participation in another investigational study;
  • •Refusal to receive blood products;
  • •Pregnant or breast-feeding women

研究组 & 干预措施

SETALUM™ Sealant

Experimental

SETALUM™ Sealant to be applied on the suture line

干预措施: SETALUM™ Sealant (Device)

结局指标

主要结局

Elapsed time from clamp release to hemostasis at the suture line

时间窗: During surgical procedure

The hemostasis is observed by the operating surgeon and timed by an operative room nurse. Anastomotic hemostasis is defined as an anastomosis not requiring any additional intervention to control bleeding.

All adverse events occurring from the surgical procedure to Week 12

时间窗: Week 12

Each Adverse Event was described by the seriouness and the nature of its relationship to the SETALUM™ Sealant or to the surgical procedure. The Data Monitoring Committee reviewed all occurred adverse events and provided a conclusion on the SETALUM™ Sealant safety profile.

次要结局

未报告次要终点

研究者

发起方
Gecko Biomedical
申办方类型
Industry
责任方
Sponsor

相似试验